ENDEAVOR IS A CLINICAL STAGE COMPANY FOCUSED ON DEVELOPING DRUGS THAT TARGET THE CAUSE OF LIFE-THREATENING DISEASES
Location: United States, California, San Diego
Employees: 11-50
Total raised: $295.5M
Founded date: 2018
Investors 3
| Date | Name | Website |
| 04.05.2022 | Crescent E... | crescenten... |
| - | Omega Fund... | omegafunds... |
| 23.01.2021 | Longitude ... | longitudec... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 24.04.2024 | Series C | $132.5M | - |
| 08.02.2022 | Series B | $101M | - |
| 07.01.2021 | Series A | $62M | - |
Mentions in press and media 14
| Date | Title | Description | Source |
| 25.04.2024 | Endeavor BioMedicines Secures $132.5M for Medical Breakthrou... | San Diego's Endeavor BioMedicines has clinched a hefty $132.5M in Series C financing, spearheaded by... | parsers.vc... |
| 24.04.2024 | Endeavor BioMedicines Gets $132.5M | San Diego-based biotechnology company Endeavor BioMedicine said this morning that it has raised $132... | socaltech.... |
| 24.04.2024 | Endeavor BioMedicines Raises $132.5M in Series C Financing | Endeavor BioMedicines, Inc., a San Diego, CA-based clinical-stage biotechnology company, closed a $1... | finsmes.co... |
| 19.10.2023 | Endeavor BioMedicines Enters License Agreement with Hummingb... | Endeavor obtains exclusive worldwide rights to Hummingbird Bioscience's anti-HER3 ADC to be develope... | en.prnasia... |
| 08.02.2022 | Endeavor BioMedicines garners $101M from a Series B funding ... | - | connect.or... |
| 08.02.2022 | San Diego’s Endeavor BioMedicines nets $101M to hunt down ge... | Endeavor BioMedicines, a precision therapy startup targeting the root drivers of cancer and other ai... | sandiegoun... |
| 08.02.2022 | Endeavor BioMedicines Gains $101M More For Precision Med... | San Diego-based Endeavor BioMedicines, a clinical-stage biotechnology company focused on oncology an... | socaltech.... |
| 07.02.2022 | Endeavor BioMedicines Closes $101M Series B Financing to Adv... | Endeavor BioMedicines, a clinical-stage biotechnology company targeting the core drivers of terminal... | marketscre... |
| 07.02.2022 | Endeavor snags $101M to go after Boehringer, Roche in lung s... | Endeavor Biomedicines wants to best the two idiopathic pulmonary fibrosis (IPF) drugs on the market ... | fiercebiot... |
| 07.02.2022 | Endeavor snags $101M to go after Boehringer, Roche in lung s... | Endeavor Biomedicines wants to best the two idiopathic pulmonary fibrosis (IPF) drugs on the market ... | fiercebiot... |
Show more